Statements (63)
Predicate | Object |
---|---|
gptkbp:instanceOf |
medical product
|
gptkbp:applicationStatus |
approved
|
gptkbp:availability |
available by prescription
available over the counter in some regions |
gptkbp:clinicalTrials |
Phase 3
study on efficacy study on safety Gelesis_400_adherence_study Gelesis_400_clinical_trial_1 Gelesis_400_clinical_trial_2 Gelesis_400_dietary_intervention_study Gelesis_400_economic_impact_study Gelesis_400_impact_on_comorbidities_study Gelesis_400_lifestyle_intervention_study Gelesis_400_long-term_safety_study Gelesis_400_long-term_study Gelesis_400_metabolic_study Gelesis_400_patient-reported_outcomes_study Gelesis_400_psychological_impact_study Gelesis_400_quality_of_life_study Gelesis_400_safety_study Gelesis_400_vs_placebo_study Gelesis_400_weight_loss_efficacy_study Gelesis_400_effectiveness_in_diverse_populations_study |
gptkbp:developedBy |
gptkb:Gelesis_Inc.
|
gptkbp:dosageForm |
capsule
|
gptkbp:formulation |
hydrogel
|
https://www.w3.org/2000/01/rdf-schema#label |
Gelesis 400
|
gptkbp:ingredients |
water
gelatin citric acid titanium dioxide glycerin potassium citrate magnesium stearate sodium alginate |
gptkbp:issuedBy |
oral capsule
|
gptkbp:manufacturer |
gptkb:Gelesis_Inc.
|
gptkbp:market |
2020
|
gptkbp:marketedAs |
brand_name_Gelesis_400
|
gptkbp:patentStatus |
patented
|
gptkbp:regulatoryCompliance |
received_FDA_approval
|
gptkbp:researchInterest |
clinical trial results
efficacy studies published in medical journals patient satisfaction studies long-term effects studies dietary impact studies metabolic effects studies safety profile studies weight loss studies comparative studies with other weight loss products |
gptkbp:route |
oral
|
gptkbp:sideEffect |
nausea
abdominal pain diarrhea |
gptkbp:suitableFor |
2 capsules before meals
|
gptkbp:targetMarket |
gptkb:Canada
gptkb:European_Union gptkb:United_States |
gptkbp:targets |
overweight and obese adults
|
gptkbp:triggerType |
expands in the stomach
|
gptkbp:usedFor |
weight management
|